NCT06398353Recruiting
Investigating the Impact of Acupuncture on the Quality of Life of Primitive Headaches Patients
Source: ClinicalTrials.gov · Last updated 7 May 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Primary headache is one of the most common neurological diseases in modern society, which seriously affects the patient's quality of life. Although the use of painkillers can alleviate primary headache symptoms, it may also cause drug dependence. Therefore, alternative therapies that do not rely on drugs have attracted increasing attention in recent years. Among them, acupuncture has been partially recognized by the public as an effective treatment for primary headaches. However, there is currently no scientific evidence that acupuncture is effective for primary headaches. The purpose of this project is to verify the effect of acupuncture in treating primary headaches. This study has three sub-projects: Subproject 2 explores the impact of acupuncture on headache severity and quality of life in patients with primary headaches. We evaluate the quality of life before and after acupuncture treatment through professional questionnaires, including the Numerical rating scale (NRS), headache diary, depression, anxiety and stress scale (DASS-21), health quality of life measurement questionnaire, Migraine Disability Assessment Scale and SF-36 Taiwan version. Finally, these data will be combined with the pulseway analysis from the results of sub-project 1 to provide a comprehensive way to evaluate the treatment effect.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 18 Mar 2024
- Start date
- 31 Jan 2024
- Primary completion date
- 1 Jun 2027
- Lead sponsor
- Chang Gung Memorial Hospital
- Diseases
- Migraine
- NCT number
- NCT06398353
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 31 Jan 2024 to the primary completion date, 1 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Willing to sign a written subject consent form
- Male or female over 18 years old
- Those who have headaches (for example: dizziness, heavy head, dizziness, head fullness, migraine), those who have headaches more than twice a week, and whose NRS score is ˃ 4.
- Headache definition: Headache symptoms are classified according to the ICHD-3 headache classification of the International Headache Organization, and are mainly primary headaches.
- Dr. Chang ,Y.-J. and Dr. Yang ,C.-C. help to exclude headache patients with the following exclusion conditions to reduce the risk to subjects.
- Exclusin Criteria
- Pregnant women
- Various acute and chronic infectious diseases, various skin ulcers, sores, burns, etc.
- The patient has injuries to the radial artery or wrist, or has steel nails, plates, or fractures.
- Various types of headaches related to anatomical structural lesions
- Headaches associated with taking or withdrawing from substances (drugs, food, or other chemicals)
- Headaches related to non-head infections and metabolic diseases
- People with painful cranial neuropathy, other facial pain and other headaches
- People with secondary headaches according to ICHD-3 beta
- Other patients who have been evaluated by physicians as not suitable for inclusion in the evaluation.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chang Gung Memorial Hospital Coordinator of this site? Confirm its status | Taoyuan | Taiwan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.